GE HealthCare reported $21.0B of revenue over the trailing twelve months, +6.0% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $21.0B (to Q1 2026). Net income: $1.91B, trailing twelve months to Q1 2026. Operating margin: 13%, trailing twelve months to Q1 2026. EPS: $4.18, trailing twelve months to Q1 2026.

GEHCGE HealthCare

Healthcare

$65.74-11% 1Y

$65.74

$59.4952 weeks$88.08

GEHC as reported

GE HealthCare reported $21.0B of revenue over the trailing twelve months, +6.0% on the year before. 10 reported series are charted on this page, each one as filed.

$21.0B

Revenue, trailing twelve months · to Q1 2026 · +6.0% against the twelve months before

Net income: $1.91B
Net income · −13% year on year · trailing twelve months to Q1 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q1 2026
EPS: $4.18
EPS · −12% year on year · trailing twelve months to Q1 2026

Details›

Every series Ryufin has for GEHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$21.0B	+6.0%	Q1 2026
Net income	$1.91B	−13%	Q1 2026
EPS	$4.18	−12%	Q1 2026
Gross margin	39%	n/a	Q1 2026
Operating margin	13%	n/a	Q1 2026
Net margin	9.1%	n/a	Q1 2026
ROE	21%	n/a	Q1 2026
ROA	5.8%	n/a	Q1 2026
ROIC	12%	n/a	Q1 2026
P/E	15.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.